1. Calpain‐1 is associated with adverse relapse free survival in breast cancer: a confirmatory study. Issue 7 (11th January 2016) Authors: Pu, Xuan; Storr, Sarah J; Ahmad, Narmeen S; Chan, Stephen Y; Moseley, Paul M; Televantou, Despina; Cresti, Nicola; Boddy, Alan; Ellis, Ian O; Martin, Stewart G Journal: Histopathology Issue: Volume 68:Issue 7(2016) Page Start: 1021 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Genetic variants in the HER2 gene: Influence on HER2 overexpression and loss of heterozygosity in breast cancer. (March 2016) Authors: Cresti, Nicola; Lee, Joanne; Rourke, Emma; Televantou, Despina; Jamieson, David; Verrill, Mark; Boddy, Alan V. Journal: European journal of cancer Issue: Volume 55(2016) Page Start: 27 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. TP53 STATUS RISK STRATIFIES PATIENTS WITH CLINICALLY DEFINED HIGH-RISK DISEASE PAEDIATRIC B-CELL NON-HODGKIN LYMPHOMA. (October 2022) Authors: Newman, Alexander M.; Zaka, Masood; Zhou, Peixun; Blain, Alex E.; Erhorn, Amy; Barnard, Amy; Crossland, Rachel E.; Wilkinson, Sarah; Enshaei, Amir; De Zordi, Julian; Harding, Fiona; Taj, Mary; Wood, Katrina M.; Televantou, Despina; Turner, Suzanne D.; Burke, G. A. Amos; Harrison, Christine J.; Bo... Journal: Leukemia research Issue: Volume 121(2022)Supplement Page Start: S51 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗